Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
NCT00378027
·
clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
enrollment criteria not met by PI patient population
Conditions
Pulmonary Embolism
Interventions
DRUG:
Fondaparinux
Sponsor
The Cleveland Clinic
Collaborators
[object Object]